Smart Beta ETF report for PBE
Pharma and biotech ETFs are in great shape and are trading at a one-month high level.
Sector ETF report for PBE
Smart Beta ETF report for PBE
Sector ETF report for PBE
Smart Beta ETF report for PBE
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Sector ETF report for PBE
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
In trading on Friday, shares of the Invesco Dynamic Biotechnology & Genome ETF entered into oversold territory, changing hands as low as $58.9119 per share. We define oversold territory using the Relative...